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CMV to replicate and eventually cause
retinitis. Takakura et al. (2014) reports
on a relatively large series of viral
retinitis following local steroid admin-
istration, but in this paper the injected
steroid was triamcinolone or ﬂuocino-
lone and the contribution of systemic
immunosuppression remained unclear.
Meanwhile, exclusion criteria of the
GENEVA Study did not include sys-
temic immunosuppressive treatment
but only the use of systemic steroids
(Haller et al. 2010). Moreover, it is
possible that in retinal vein occlusion,
the retinal blood ﬂow stasis and the
breakdown in the blood–retina barrier
may increase the susceptibility of ocu-
lar tissues to virus penetration. In
conclusion, ophthalmologists using in-
travitreal steroids in iatrogenic com-
promised patients should be aware of
the potential risk of CMV retinitis.
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Editor,
I ntravitreal ocriplasmin, a recombi-nant truncated form of plasmin
with proteolytic activity against lami-
nin and ﬁbronectin (Hermel et al.
2010), has recently been approved as
treatment strategy for vitreomacular
traction (VMT). However, concerns
have been raised regarding its ocular
safety (Kim 2014). Clinical trials
reported adverse events that included
transient visual loss, dyschromatopsia
and photopsias, usually associated
with decreased amplitudes on electro-
retinography (ERG) (Stalmans et al.
2012). Spectral domain optical coher-
ence tomography (SD-OCT) abnor-
malities have been detected within
the macula, and ERG studies have
demonstrated diﬀuse retinal dysfunc-
tion related to presumed ocriplasmin
toxicity (Fahim et al. 2014; Tibbetts
et al. 2014). Herein, we demonstrate
that early structural abnormalities to
the photoreceptors as detected by
fundus autoﬂuorescence (FAF) and
SD-OCT may aﬀect not only the
macula but also the peripheral retina
as well.
A 69-year-old woman presented
with visual acuity of 20/32 and meta-
morphopsia in her right eye. Fundus
examination and SD-OCT revealed
VMT with small detachment of the
foveal cones; FAF was normal
(Fig. 1A,E). The day after uneventful
intravitreal ocriplasmin (0.125 mg/
0.1 ml), her vision decreased to 20/50
and she complained of dyschromat-
opsia. SD-OCT demonstrated the
appearance of subfoveal ﬂuid and
multifocal shallow subretinal detach-
ments (Fig. 1J–L), as well as focal
areas of attenuation/thinning of the
ellipsoid zone line and disappearance
of the interdigitation zone line of the
photoreceptors. Photoreceptor abnor-
malities corresponded to patchy areas
of abnormally increased FAF signal
within the macula (Fig. 1B,F) as well
as to radial lines of abnormally
increased FAF signal towards the ret-
inal periphery (Fig. 1I). At day 7, her
vision improved to 20/40 and dyschro-
matopsia was resolved. SD-OCT dem-
onstrated the released VMT, decreased
subfoveal ﬂuid and shaggy photorecep-
tors in the fovea (Fig. 1C,G). Persisting
attenuation/thinning of the ellipsoid
zone line and further disappearance of
the interdigitation zone line were
noted. After 4 months, FAF and SD-
OCT abnormalities disappeared com-
pletely (Fig. 1D,H).
Clinical trials that compared intra-
vitreal ocriplasmin to placebo in treat-
ment of VMT indicated that visual
symptoms were greater in patients
receiving ocriplasmin (Stalmans et al.
2012). In addition, decreased ampli-
tudes in all ERG variables were noted,
indicating the presence of panretinal
dysfunction that persisted for several
months (Fahim et al. 2014; Tibbetts
et al. 2014). Our imaging study sup-
ports these functional ﬁndings; indeed,
structural damage to the photorecep-
tors was not conﬁned within the
macula, but was actually widespread
throughout the periphery. These
abnormalities may be due to a protease
eﬀect on laminin, which is present not
only in the vitreous but also through-
out the retina, including the interpho-
toreceptor matrix (IPM) (Fahim et al.
2014). Interestingly, in our case, there
was greater and broader damage to the
interdigitation zone line compared to
the ellipsoid zone line. Normal reﬂec-
tivity of the interdigitation zone line
arises from well-oriented and aligned
interdigitations of apical processes of
the retinal pigment epithelium (RPE)
with outer segments of the photorecep-
tors. We hypothesize that lysis of the
IPM caused by ocriplasmin may create
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a loss of the normal alignment between
photoreceptors and RPE microvilli,
therefore causing reduced reﬂectivity
of the interdigitation zone line. In
addition, given the pivotal role of a
healthy IPM for maintaining adhesion
between retina and RPE, lysis of the
IPM may reduce strength of the adhe-
sion and thus cause multifocal detach-
ments of the retina in areas where
vitreoretinal traction was not signiﬁ-
cant.
In summary, although ocriplasmin is
eﬀective in releasing VMT, presumed
toxic eﬀects of the drug may lead to
visual disturbances as well as to early
but transient panretinal structural
abnormalities, especially involving the
interdigitation zone. We suggest evalu-
ating carefully the retinal periphery after
ocriplasmin injection to detect any pos-
sible toxicity for the photoreceptors.
Given the limited follow-up of patients
who experienced presumed ocriplasmin
toxicity, further research is needed to
investigate risk factors, duration of
recovery and ways to prevent or mini-
mize toxic eﬀects of the drug.
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Fig. 1. Baseline horizontal wide-angle SD-OCT scan centred on the fovea (A, E) shows vitreomacular traction (VMT), as well as vitreous attachment
peripapillary and temporally to the macula. A small detachment of the cones is well visible subfoveally, and well-delineated lines corresponding to the
ELM, ellipsoid zone, interdigitation zone and retinal pigment epithelium (RPE) are present throughout the entire scan. Fundus autoﬂuorescence
(FAF) is normal. At day 1 after intravitreal ocriplasmin injection (B, F), SD-OCT scan reveals persistent VMT, appearance of subretinal ﬂuid in the
fovea, as well as perifoveal areas of attenuation/thinning of the ellipsoid zone line and disappearance of the interdigitation zone line of the
photoreceptors. Wide-angle FAF (I) reveals patchy areas of increased signal within the macula, as well as lines of increased signal with a radial
distribution from the optic disc head towards the periphery. Beside thinning or disappearance of photoreceptors lines, multifocal shallow detachments
(arrows) of the retina from the RPE (J–L) are appreciated superonasally to the fovea, subfoveally and peripapillary, and inferiorly to the macula and
optic disc. At day 7 (C, G), VMT has been released, subfoveal ﬂuid has decreased, and shaggy photoreceptors are present in the fovea. The ellipsoid
zone line is persistently attenuated, but the interdigitation zone line has experienced further and more diﬀuse disappearance. FAF is substantially
unchanged from day 1. At month 4 (D, H), SD-OCT shows complete vitreous detachment, resolved subfoveal ﬂuid and complete restoration of the
outer retinal layers. FAF abnormalities resolved.
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Editor,
I n primary congenital glaucoma(PCG), even after initial successful
intra-ocular pressure (IOP) control
with prompt surgical intervention,
PCG children still face vision-threaten-
ing diﬃculties, such as corneal scarring
and anisometropia, and resultant
amblyopia (M S 2005). De Silva et al.
(2011) reported a lack of progression
rate in 90.3% of patients after 1 year,
70.8% at 10 years and 48.6% at
40 years and also reported that stable
PCG patients could have glaucoma-
tous progression with sight threatening
complications when followed for a
prolonged time. We evaluated the
long-term outcome according to surgi-
cal interventions, prognosis related to
visual acuity, IOP and ocular morbidi-
ties in South Korean patients.
Medical records of PCG patients
from seven hospitals in South Korea
were examined. Mean follow-up period
was 137.8 months. Statistical analyses
were conducted using SAS version 9.3
(SAS Institute, Cary, NC, USA) and
package ‘PRODLIM’ in R 2.13.2 (Vienna,
Austria; http://www.R-project.org). In
a total of 154 eyes of 92 PCG patients,
50.64% received one operation and
45.2% received more than two opera-
tions. Qualiﬁed success rate deﬁned as
a ﬁnal IOP <21 mmHg with or without
antiglaucoma medications was 70.6%
and 61.8% at postoperative 1 and
5 years, respectively. In success rate
analysing with Kaplan–Meier method
for clustered data, the probability that
requires a second operation was 29.4%
at 1 year, 33.3% at 5 years and 38.2%
at 10 years (Fig. 1). Thereafter, the
slope of the probability of a second
operation became stable. Final prog-
nosis were categorized according to
World Health Organization classiﬁca-
tion of visual impairment and IOP
control (Group 1: IOP well controlled,
no visual impairment; Group 2: IOP
well controlled, low vision; Group 3:
IOP well controlled, lower vision;
Group 4: legally blind; Group 5:
uncontrolled IOP). Groups 1, 2 and 3
comprised 33.7%, 21.3% and 21.3% of
PCG patients, respectively. About
19.1% had blindness in one or both
eyes. Although IOP is often well con-
trolled after surgical intervention, over
half (61%) of the PCG patients had
visual impairment. Mean visual acuity
at the ﬁnal visit was 0.48, when exclud-
ing lower than ﬁnger count, and mean
IOP was 15.2 mmHg. In multivariate
analysis of the association of prognosis
and other ocular factors, the number of
surgical interventions was weakly
positively correlated with poor prog-
nosis (Spearman’s correlation coeﬃ-
cient = 0.31154, p = 0.004). Other
factors including the involvement of
both eyes, age at initial presentation,
sex and IOP at initial presentation were
not statistically associated with ﬁnal
prognosis (all p > 0.05). About 20.9%
still had amblyopia, excluding the
number of patients who displayed
improved vision after amblyopia
therapy, and 13.9% had strabismus
at the most recent visit or had previ-
ously received strabismus surgery. In
univariate and multivariate analyses,
the presence of these ocular morbidi-
ties was not associated with age at
initial presentation, sex, IOP at initial
presentation or the number of surgical
interventions (all p > 0.05). Three
patients had retinal detachment, and
one had suprachoroidal haemorrhage.
These complications were associated
with IOP at initial presentation in
both univariate and multivariate
analysis (p = 0.009 and 0.026, respec-
tively).
In conclusion, the probability of a
second operation after the ﬁrst inter-
vention was continuously increased
during follow-up. In ﬁnal prognosis,
Fig. 1. Survival probability after ﬁrst intervention using Kaplan–Meier method for clustered data.
X-axis represents time (months), and Y-axis represents survival probability. Qualiﬁed success rate
was 70.6% at the ﬁrst year and 61.8% at 5 years, when deﬁned as a ﬁnal intra-ocular pressure
(IOP) <21 mmHg with or without antiglaucoma medications. The probability that primary
congenital glaucoma (PCG) patients will receive second operation was 29.4% at 1 year, 33.3% at
5 years and 38.2% at 10 years, after which the slope stabilized.
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